Stelzer Laurie
SEC insider (Form 3/4/5 filer). CIK 0001644348. Director at Sionna Therapeutics, Inc. (SION) and 3 other issuers. 8 reported Form 4/5 transactions since Sep 2024; latest on Jun 17, 2026. Located in CARMEL, IN.
Companies Stelzer Laurie has filed insider reports for
- Sionna Therapeutics, Inc. (SION): Director
- PMV Pharmaceuticals, Inc. (PMVP): Director
- MBX Biosciences, Inc. (MBX): Director
- Spyre Therapeutics, Inc. (SYRE): Director
Stelzer Laurie
CIK: 0001644348
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Jun 17, 2026SION
Sionna Therapeutics, Inc.
AwardDirectNon-Qualified Stock Option (right to buy)
17.3K shares- - Jun 4, 2026PMVP
PMV Pharmaceuticals, Inc.
AwardDirectStock Option (right to buy)
42K shares- - Jun 4, 2026MBX
MBX Biosciences, Inc.
AwardDirectStock option (right to buy)
12.5K shares- - May 27, 2026SYRE
Spyre Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
8K shares- - Jan 20, 2026MBX
MBX Biosciences, Inc.
AwardDirectStock option (right to buy)
32K shares- - Jun 12, 2025SION
Sionna Therapeutics, Inc.
AwardDirectNon-Qualified Stock Option (right to buy)
20K shares- - Jun 5, 2025PMVP
PMV Pharmaceuticals, Inc.
AwardDirectStock Option (right to buy)
33.5K shares- - May 29, 2025SYRE
Spyre Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
25K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 17, 2026 |  SION Sionna Therapeutics, Inc. | Award Non-Qualified Stock Option (right to buy) | 17,340 | - | - | Direct |
| Jun 4, 2026 |  PMVP PMV Pharmaceuticals, Inc. | Award Stock Option (right to buy) | 42,000 | - | - | Direct |
| Jun 4, 2026 |  MBX MBX Biosciences, Inc. | Award Stock option (right to buy) | 12,500 | - | - | Direct |
| May 27, 2026 |  SYRE Spyre Therapeutics, Inc. | Award Stock Option (Right to Buy) | 8,026 | - | - | Direct |
| Jan 20, 2026 | MBX MBX Biosciences, Inc. | Award Stock option (right to buy) | 32,000 | - | - | Direct |
| Jun 12, 2025 | SION Sionna Therapeutics, Inc. | Award Non-Qualified Stock Option (right to buy) | 19,959 | - | - | Direct |
| Jun 5, 2025 | PMVP PMV Pharmaceuticals, Inc. | Award Stock Option (right to buy) | 33,500 | - | - | Direct |
| May 29, 2025 | SYRE Spyre Therapeutics, Inc. | Award Stock Option (Right to Buy) | 25,000 | - | - | Direct |
1-8 of 8 transactions